Literature DB >> 23258645

Chronic scrotal pain syndrome (CSPS): the widespread use of antibiotics is not justified.

R T Strebel1, C Schmidt, J Beatrice, T Sulser.   

Abstract

Data supporting the widespread use of antibiotics in patients with chronic scrotal pain syndrome (CSPS) are not available. Therefore, the aim of this study was to investigate the presence of bacteria in the genitourinary tract in patients presenting with CSPS. From July 2005 to July 2007 we prospectively enrolled patients presenting with CSPS in our outpatient clinic. The evaluation consisted of a detailed patient's history, physical examination and ultrasound examination of the scrotum. A blood and urinalysis, a Meares-Stamey four-glass test for bacterial cultures and PCR testing for Chlamydia trachomatis, Ureaplasma urealyticum, Mycoplasma hominis and Neisseria gonorrhoeae as well as a semen culture were performed. We assessed the symptom severity with the chronic epididymitis symptom index (CESI) score according to Nickel et al. (J Urol 2002, 167:1701; based on the NIH-CPSI). A total of 55 eligible men (median age 34 years) with CSPS were enrolled in the study. The median CESI score was 17 (range 4-26). The majority of patients (n = 39; 71%) were seen by a general practitioner or an urologist before. Of these, 25 patients (64%) were treated with antibiotics and 26 (67%) with non-steroidal anti-inflammatory drugs, respectively. A significant bacterial colony count in at least one specimen was detected in 21 of 55 patients (38%). The predominantly detected microorganisms were an Alpha-haemolytic Streptococcus (11 patients) and coagulase-negative staphylococci (10 patients). Thus, only in 12 of 55 (22%) patients isolated bacteria were considered to be of clinical relevance. No factor or condition predictive for a bacterial aetiology for CSPS could be identified. In our microbiological assessment of patients presenting with CSPS we found no evidence for the widely held belief that CSPS is predominantly the result of a chronic bacterial infection. We therefore conclude that the widespread use of antibiotic agents in the treatment of patients with CSPS is not justified.
© 2012 American Society of Andrology and European Academy of Andrology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23258645     DOI: 10.1111/j.2047-2927.2012.00017.x

Source DB:  PubMed          Journal:  Andrology        ISSN: 2047-2919            Impact factor:   3.842


  8 in total

1.  Evaluation and Management of Chronic Scrotal Content Pain-A Common Yet Poorly Understood Condition.

Authors:  Matthew J Ziegelmann; M Ryan Farrell; Laurence A Levine
Journal:  Rev Urol       Date:  2019

Review 2.  Chronic Scrotal Pain.

Authors:  Christopher Wu; Keith Jarvi
Journal:  Curr Urol Rep       Date:  2018-05-31       Impact factor: 3.092

3.  Canadian Urological Association best practice report on chronic scrotal pain.

Authors:  Keith A Jarvi; Christopher Wu; J Curtis Nickel; Trustin Domes; John Grantmyre; Armand Zini
Journal:  Can Urol Assoc J       Date:  2018-02-23       Impact factor: 1.862

Review 4.  Management of Chronic Orchialgia: Challenges and Solutions - The Current Standard of Care.

Authors:  Sijo J Parekattil; Onuralp Ergun; Ahmet Gudeloglu
Journal:  Res Rep Urol       Date:  2020-07-02

Review 5.  Epididymitis: revelations at the convergence of clinical and basic sciences.

Authors:  Vera Michel; Adrian Pilatz; Mark P Hedger; Andreas Meinhardt
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

6.  Efficacy and Safety of Ningmitai Capsules in Patients with Chronic Epididymitis: A Prospective, Parallel Randomized Controlled Clinical Trial.

Authors:  Zhang Jing; Guan Liying; Wang Zhenqing; Zhang Hui; Liu Shuai; Sun Dingqi; Fu Qiang; Zhang Keqin
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-27       Impact factor: 2.629

Review 7.  Medical management of chronic orchialgia.

Authors:  Nathan R Starke; Raymond A Costabile
Journal:  Transl Androl Urol       Date:  2017-05

8.  Ultrasound aspects of symptomatic versus asymptomatic forms of male accessory gland inflammation.

Authors:  Sandro La Vignera; Andrea Crafa; Rosita A Condorelli; Federica Barbagallo; Laura M Mongioì; Rossella Cannarella; Michele Compagnone; Antonio Aversa; Aldo E Calogero
Journal:  Andrology       Date:  2021-05-06       Impact factor: 3.842

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.